Peptid-Klartext DE Community
Weight loss & metabolism

Adipotide: Effects, Evidence and Risks

Research use only: Adipotid is not approved as a medicine. It is offered as a research substance labelled “for research purposes only – not for use in humans or animals”. This page summarises the state of research and is not a recommendation to use it.

Also known as FTPP, prohibitin-targeting peptide 1.

StatusNot approved
EvidencePreclinical
Drug classExperimental vessel-destroying peptide · injection
Add as vial in tracker

We only show doses for approved medicines according to the prescribing information – in the calculator.

What is Adipotide?

A peptide that binds to the protein prohibitin on blood vessels of white fat tissue and triggers cell death there. The fat tissue loses its blood supply and is broken down – the approach originally comes from cancer research.

How well studied is Adipotide?

Animal data only: obese rhesus monkeys lost an average of roughly 11 % of body weight in four weeks (2011). A human trial in prostate cancer patients was announced; there are no reliable published results in humans.

What side effects and risks does Adipotide have?

Dose-dependent kidney damage already occurred in animal studies. Because the mechanism deliberately kills tissue, unintended damage to other organs cannot be ruled out. There are no safety data for humans.

Is Adipotide approved in Germany?

In short: no. Not approved anywhere, and no ongoing development as a weight-loss drug is known. As a non-approved substance it falls under S0 of the WADA Prohibited List. Online products („research chemicals“) are untested; content and purity are unknown.

Sources

Note: We deliberately do not list any doses here. For approved medicines, your doctor sets the dose; for unapproved substances there is no reliable information.